Surgical Disorders of the Liver
Liver Abscess
Dr. Taha K.
2024
PYOGENIC LIVER ABSCESS
Incidence
• The incidence of pyogenic liver abscess is on
the rise( 15/100000)
• single or multiple and are more frequently
found in the right lobe of the liver
Predisposing Factor
Pathology
• The Source of the liver abscess is predictive of the
number, location, and size
of the abscess affecting a given patient.
• Portal, traumatic, and cryptogenic hepatic abscesses
are solitary and large, whereas biliary and arterial
abscesses are multiple and small.
• Bilateral disease may be seen in 90% of patients with
an arterial or biliary source
• Fungal abscesses are usually multiple, bilateral, and
miliary.
Bacteriology
40% of abscesses are monomicrobial, 40% are polymicrobial,
and 20% are culture-negative.
most common infecting agents are gram-negative bacteria.
Escherichia coli is found in two thirds of cases, and other
common organisms include Streptococcus faecalis,
Klebsiella, and Proteus
vulgaris.
Anaerobic organisms such as Bacteroides fragilis also
are seen frequently.
In endocarditis and infected indwelling catheters,
Staphylococcus and Streptococcus species
Clinical Presentation
• Classic triad of fever, jaundice, and right upper
quadrant tenderness in less than 10% case
Diagnostic Investigation
• CBC, BG and RH
• LFT, Coagulation profile, Albumin
• ESR,
• Blood Culture and Sensitivity..50%
• Abdominal Ultrasound
• Abdominal CT Scan.. Diagnostic and theraptic
• Abdominal MRI
Treatment
• The appropriate treatment for pyogenic liver abscesses
requires treatment of the abscess itself and concomitant
treatment of the source
• Steps in management include antibiotic administration,
radiologic confirmation by US or CT, and drainage.
• Exceptions to this strategy include multiple small
abscesses and miliary fungal abscesses. These abscesses
are treated with intravenous antibiotics and antifungals,
respectively, without a drainage procedure.
Modality of Treatment
• Antibiotics
• Antifungal Treatment
• Needle aspiration and percutaneous catheter
drainage
• Surgical drainage (lap or Open)
• Liver resection-recalcitrant abscesses
Antibiotics
• Classic antibiotic regimens include an
aminoglycoside /Fluoroquinolones, clindamycin
/metronidazole, and either ampicillin or vancomycin
• Treatment used to be given for 4 to 6 weeks;
• Antibiotics alone have an 80% success rate for
solitary abscesses with a diameter <5 cm. In patients
with unilocular hepatic abscesses of <3 cm, treatment
with antibiotics alone had a 100% success rate.
Complications
• Up to 40% of patients develop complication
• Most common being generalized sepsis
• Other pleural effusions, empyema, and
pneumonia.
• Abscesses also may rupture intraperitoneally
• Perihepatic abscess.
• Hemobilia and hepatic vein thrombosis
AMEBIC LIVER ABSCESS
Amebic Liver Abscess
• Should be considered in every case of solitary
abscess
• Is the most common extra intestinal manifestation
of amebiasis
• The parasite exist in 2 forms: an infective cyst
stage and a trophozoite stage whichis the form
causes invasive disease
• Presentation usually happen within 4 months
after rturn from an endemic area
• Etiology- Entamoeba Histolytica
• Source:- Portal vein from gut(Amebic dysentry). The
anteedent intestinal phae has subsided by the time patient
presents
• Mainly adult man( 10x) despite equal sex distribution of
intestinal amebiasis
• Pathology: liquefactive necrosis of the liver (Cavity full of
blood andliquefied liver tissue)
• This fluid is described as ‘Anchovy sauce’ chocolate/odorless
unless secondary bacterial infection (20%) occurs.
Clinical feature
• Persistant fever/RUQ pain/anorexia/ history of
dysentry/hepatomegally and point tendernessover the
liver.
• General symptom is less than pyogenic abscess but
local is more than
• Diagnosis: Ultrasound and CT
• Stool “Amoeba are found in fresh stool examination in
15% of the cases
• Serology” indirect hemagglutination test is 100%
positive
Fate
• Resolution or complications (20% mortality)
as secondary infection “20%”
• Chronicity
• erosion into surrounding structures
• Free rupture into the peritoneum
Treatment
• Metronidazole 500mg IV 6hourly or then orally
( 750mg orally TID ) for 7 to 10 days
• After complication of the course of
Metronidazole ,intraluminal agent as diloxanide
furoarate should be used to eradicate cyst even if
stools ared negative for amebae
• Percutaneous drainage if refractory to metronidazole
or bacterial superinfection
• Surgery is indicated only if failed other lines of
treatment or complications as rupture

Liver Abscess internal medicine surgery l

  • 1.
    Surgical Disorders ofthe Liver Liver Abscess Dr. Taha K. 2024
  • 2.
  • 3.
    Incidence • The incidenceof pyogenic liver abscess is on the rise( 15/100000) • single or multiple and are more frequently found in the right lobe of the liver
  • 4.
  • 5.
    Pathology • The Sourceof the liver abscess is predictive of the number, location, and size of the abscess affecting a given patient. • Portal, traumatic, and cryptogenic hepatic abscesses are solitary and large, whereas biliary and arterial abscesses are multiple and small. • Bilateral disease may be seen in 90% of patients with an arterial or biliary source • Fungal abscesses are usually multiple, bilateral, and miliary.
  • 6.
    Bacteriology 40% of abscessesare monomicrobial, 40% are polymicrobial, and 20% are culture-negative. most common infecting agents are gram-negative bacteria. Escherichia coli is found in two thirds of cases, and other common organisms include Streptococcus faecalis, Klebsiella, and Proteus vulgaris. Anaerobic organisms such as Bacteroides fragilis also are seen frequently. In endocarditis and infected indwelling catheters, Staphylococcus and Streptococcus species
  • 7.
    Clinical Presentation • Classictriad of fever, jaundice, and right upper quadrant tenderness in less than 10% case
  • 8.
    Diagnostic Investigation • CBC,BG and RH • LFT, Coagulation profile, Albumin • ESR, • Blood Culture and Sensitivity..50% • Abdominal Ultrasound • Abdominal CT Scan.. Diagnostic and theraptic • Abdominal MRI
  • 9.
    Treatment • The appropriatetreatment for pyogenic liver abscesses requires treatment of the abscess itself and concomitant treatment of the source • Steps in management include antibiotic administration, radiologic confirmation by US or CT, and drainage. • Exceptions to this strategy include multiple small abscesses and miliary fungal abscesses. These abscesses are treated with intravenous antibiotics and antifungals, respectively, without a drainage procedure.
  • 10.
    Modality of Treatment •Antibiotics • Antifungal Treatment • Needle aspiration and percutaneous catheter drainage • Surgical drainage (lap or Open) • Liver resection-recalcitrant abscesses
  • 11.
    Antibiotics • Classic antibioticregimens include an aminoglycoside /Fluoroquinolones, clindamycin /metronidazole, and either ampicillin or vancomycin • Treatment used to be given for 4 to 6 weeks; • Antibiotics alone have an 80% success rate for solitary abscesses with a diameter <5 cm. In patients with unilocular hepatic abscesses of <3 cm, treatment with antibiotics alone had a 100% success rate.
  • 12.
    Complications • Up to40% of patients develop complication • Most common being generalized sepsis • Other pleural effusions, empyema, and pneumonia. • Abscesses also may rupture intraperitoneally • Perihepatic abscess. • Hemobilia and hepatic vein thrombosis
  • 14.
  • 15.
    Amebic Liver Abscess •Should be considered in every case of solitary abscess • Is the most common extra intestinal manifestation of amebiasis • The parasite exist in 2 forms: an infective cyst stage and a trophozoite stage whichis the form causes invasive disease • Presentation usually happen within 4 months after rturn from an endemic area
  • 16.
    • Etiology- EntamoebaHistolytica • Source:- Portal vein from gut(Amebic dysentry). The anteedent intestinal phae has subsided by the time patient presents • Mainly adult man( 10x) despite equal sex distribution of intestinal amebiasis • Pathology: liquefactive necrosis of the liver (Cavity full of blood andliquefied liver tissue) • This fluid is described as ‘Anchovy sauce’ chocolate/odorless unless secondary bacterial infection (20%) occurs.
  • 17.
    Clinical feature • Persistantfever/RUQ pain/anorexia/ history of dysentry/hepatomegally and point tendernessover the liver. • General symptom is less than pyogenic abscess but local is more than • Diagnosis: Ultrasound and CT • Stool “Amoeba are found in fresh stool examination in 15% of the cases • Serology” indirect hemagglutination test is 100% positive
  • 18.
    Fate • Resolution orcomplications (20% mortality) as secondary infection “20%” • Chronicity • erosion into surrounding structures • Free rupture into the peritoneum
  • 19.
    Treatment • Metronidazole 500mgIV 6hourly or then orally ( 750mg orally TID ) for 7 to 10 days • After complication of the course of Metronidazole ,intraluminal agent as diloxanide furoarate should be used to eradicate cyst even if stools ared negative for amebae • Percutaneous drainage if refractory to metronidazole or bacterial superinfection • Surgery is indicated only if failed other lines of treatment or complications as rupture